Wake Research is in the Raleigh-Durham-Chapel Hill area of North Carolina. The area is sometimes refered to as Research Triangle Park, RTP or 'The Triangle.
While Wake Research is in Raleigh, it draws volunteers from the entire metropolitian area. As of 2010, the United States Census Bureau indicated that the Raleigh-Durham-Cary Combined Statistical Area had a population of 1,742,816. This includes portions of Wake, Durham, Orange, Chatham Johnston, Franklin, Person and Harnett counties.
Here are some specific demographics for Wake County according to the 2010 US Census.
|
GENDER |
|---|
|
Male |
48.7% |
|
Female |
51.3% |
|
AGE |
|---|
|
Under age 5 |
7.3% |
|
Under age 18 |
26.0% |
|
Age 65+ |
8.5% |
|
RACE |
|---|
|
White |
66.1% |
|
Hispanic or Latino |
9.8% |
|
Black or African American |
20.7% |
|
American Indian and Alaska Native |
0.5% |
|
Asian |
5.4% |
|
Hawaiian and other Pacific Islanders |
0.0% |
|
Two or More Races |
2.5% |
Other Demographics
(2006-2010 Average) |
|
|
Persons Foreign Born |
12.7% |
Language other than English spoke at home
% age 5+ |
15.9% |
|
Veterans (population) |
54,158 |
Wake Research is home to the Wake Research family of companies, headquartered near Research Triangle Park, North Carolina and servicing surrounding metropolitan areas, including Wake, Johnston, Nash, Durham and Orange Counties, and the cities of Raleigh, Durham, Chapel Hill, Cary, Apex, Holly Springs, Garner, Clayton, Knightdale, Wake Forest, Creedmoor and beyond.
Wake Research is a unique and innovative resource site for Phase I, Phase II, Phase III and Phase IV clinical trials. We offer a wide variety of trial studies that may be suitable for a diverse pool of qualified individuals including, Cancer, Crohn's Disease, Ulcerative Colitis and Irritable Bowel Syndrome.
